A lower dose formulation of Bayer and Janssen’s bloodthinner Xarelto has been approved by European regulators for preventing recurrent venous thromboembolism, expanding treatment options for patients. http://www.pharmatimes.com/news/eu_oks_low-dose_xarelto_to_prevent_recurrent_vte_1210333
ST. PAUL, Minn., Oct. 17, 2017 /PRNewswire/ — Two new studies by pharmacy benefit manager Prime Therapeutics LLC (Prime) show commercially insured members with rheumatoid arthritis (RA) had 3.5 times higher total cost of care than members without RA. But optimizing conventional disease… https://www.prnewswire.com/news-releases/prime-therapeutics-studies-examine-rheumatoid-arthritis-therapies-and-total-cost-300536842.html
How should marketers position this new type of cancer therapy? http://www.mmm-online.com/sponsored/4-ways-to-market-car-t-therapies/article/699920/
The factors shaping the healthcare landscape in emerging markets require pharma to take a different approach to how it works in more developed economies. https://pharmaphorum.com/views-and-analysis/healthcare-emerging-markets/
Discontinues its new-generation treatments but Zepatier is still making headway http://www.pmlive.com/pharma_news/merck_pulls_out_of_hepatitis_c_r_and_d_as_market_shrinks_1206662
Humira is the key drug for AbbVie, and one the company hopes it will be able to push into the $20 billion region per year region before competition arrives. After a financial deal was agreed with Amgen, it looks like the drug should have the immediate biosimilar threat removed from its path running up to the beginning of 2023.
read more http://www.pharmafile.com/news/515253/five-more-biosimilar-free-years-abbvie-s-humira
The regulator hopes to improve how it reviews digital medical devices, aiming to streamline the path to market for new health tools. http://www.healthcaredive.com/news/apple-fitbit-among-companies-selected-for-fda-digital-health-precertificat/505867/
Trishna Bharadia, Multiple Sclerosis patient advocate, wants to make MS care more patient-centric.
The post 5 questions: making Multiple Sclerosis care more patient-centric appeared first on Pharmaphorum. https://pharmaphorum.com/views-and-analysis/multiple-sclerosis-patient-centric/